SCHEMBL6829341

SCHEMBL6829341

CN1CCN(c2ccc([N+](=O)[O-])cc2-c2ccc(C#N)cc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.54
LMNA P02545 6/20 0.54
GAA P10253 4/20 0.52
SLC6A9 P48067 1/20 0.48
SLC6A5 Q9Y345 1/20 0.48
MAPT P10636 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2C19 P33261 2/20 0.48
HTT P42858 2/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
SIRT6 Q8N6T7 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
WDR5 P61964 2/20 0.46
POLB P06746 1/20 0.46
HTR7 P34969 1/20 0.45
KCNJ1 P48048 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282589 0.84 ALDH1A1 (0.62) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL5652459 0.81 ALDH1A1 (0.76) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL30346122 0.77 ALDH1A1 (0.49) ALDH1A1LMNAGAASMN1; SMN2CYP1A2
SCHEMBL28504649 0.77 HTT (0.50) ALDH1A1LMNAGAASMN1; SMN2CYP1A2
SCHEMBL26092046 0.77 ALDH1A1 (0.49) ALDH1A1LMNAGAASMN1; SMN2CYP1A2
SCHEMBL22495332 0.76 SLC6A9 (0.61) ALDH1A1LMNAGAASLC6A9SLC6A5
SCHEMBL30410222 0.74 ALDH1A1 (0.61) ALDH1A1LMNAGAASMN1; SMN2CYP1A2
SCHEMBL30464734 0.74 ALDH1A1 (0.66) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL2461666 0.74 ALDH1A1 (0.66) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL15961236 0.74 SIRT6 (0.59) ALDH1A1LMNAGAASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046118-A2 2-4-(DI-PHENYL-AMINO)-PYRIMIDINE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-03 WO disclosed